reference/8662722

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8662722

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	625
issn	1474-4422
issueIdentifier	7
pageRange	618-625
publicationName	The Lancet. Neurology
startingPage	618
bibliographicCitation	Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011 Jul;10(7):618–25. doi: 10.1016/s1474-4422(11)70108-9. PMID: 21640651.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7208b31a3d1b33f0418ff53f8d99c0ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fe590e5b2225124d7566c06b0fff407 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5417b1d280c3a4695c802849c96627d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5a14a7ed427aa810c07c736f8a97751 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_376ad6f79c11816e68edf32692c08a5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d73ea52d20c1c3ec82376c2dd2aa2d06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_620f7c7937783ee3fe53c48d8432c1e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e341515ee0c6c94c836c7d5b428bda5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_209ede6d87a0dc5d92b5c6073d597921 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_217d8c2d26b0adc10db681f6d8391c38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4f4dcf6600c34ad26faadde634a6fe7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37bc0108a6fe54a667ef0b6d808905fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e73793cb63a471ad8fd49ec7a13b5bfb
date	201107
identifier	https://pubmed.ncbi.nlm.nih.gov/21640651 https://doi.org/10.1016/s1474-4422%2811%2970108-9
isPartOf	https://portal.issn.org/resource/ISSN/1474-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30413
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)
discusses	http://id.nlm.nih.gov/mesh/M0587498 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0499083 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0006497 http://id.nlm.nih.gov/mesh/M0021253
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013345Q000188 http://id.nlm.nih.gov/mesh/D011725Q000627 http://id.nlm.nih.gov/mesh/D013777Q000627 http://id.nlm.nih.gov/mesh/D065130 http://id.nlm.nih.gov/mesh/D013449Q000627 http://id.nlm.nih.gov/mesh/D020301Q000517 http://id.nlm.nih.gov/mesh/D004146Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D020301Q000401 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D013345Q000601 http://id.nlm.nih.gov/mesh/D020301Q000209 http://id.nlm.nih.gov/mesh/D020301Q000188 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013525 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D023261 http://id.nlm.nih.gov/mesh/D013345Q000401 http://id.nlm.nih.gov/mesh/D013345Q000150
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9322 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8652 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8135 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10045 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7216 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433095 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10546 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128483327

Total number of triples: 69.